Cryoport shares rally following Blackstone's bet on cell and gene therapy; Dyal's latest GP stakes fund expected to surpass $5bn target; Levine Leichtman buys Bridgepoint Development's BigHand
Blackstone invests in Cryoport causing the latter's stock to soar and Levine Leichtman acquires BigHand from Bridgepoint Development.
31 August 2020•2 mins read
